Academic Journal

Human Psychopharmacology

8 Papers Indexed in Blossom

Published Papers

Paywallindividual

Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment-resistant depression

In a randomised, double‑blind trial of single subanaesthetic infusions of racemic ketamine or esketamine in 61 people with treatment‑resistant major depressive disorder, higher baseline illness severity and a greater number of prior treatment failures predicted poorer outcomes. Specifically, more treatment failures and greater severity were associated with lower odds of remission at 7 days and reduced likelihood of response at 24 hours.

Published
Journal
Human Psychopharmacology
Authors
Bandeira, I. D., Caliman-Fontes, A. T., Correia-Melo, F. S., Echegaray, M. VF., Guerreiro-Costa, L. N. F., Jesus-Nunes, A. P., Kapczinski, F., Lacerda, A. L. T., Leal, G. C., Machado-Vieira, R., Marback, R. F., Mello, R. P., Quarantini, L. C., Santos-Lima, C., Souza-Marques, B.
Open Accessindividual

Genie in a blotter: A comparative study of LSD and LSD analogues’ effects and user profile

Using data from the Global Drug Survey, the authors found that users of LSD analogues (AL‑LAD, 1P‑LSD, ETH‑LAD)—most of whom had also used LSD—reported similar time‑to‑peak (~2 hr) and duration (~8 hr) but significantly weaker subjective effects (pleasurable high, strength, comedown, urge to reuse), lower value for money and lower perceived risk than LSD; many obtained analogues online and almost all used them orally. The paper recommends chemical confirmation and dose measurement in future studies to validate these self‑report findings.

Published
Journal
Human Psychopharmacology
Authors
Barratt, M. J., Coney, L. D., Ferris, J. A., Maier, L. J., Winstock, A. R.

Quick Facts

Papers Indexed
8
h-Index
87
Open Access
No
Publisher
John Wiley & Sons
Country
United Kingdom
Website
Visit